| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005158212 |
| P356 | DOI | 10.1007/S00228-009-0729-1 |
| P932 | PMC publication ID | 2805799 |
| P698 | PubMed publication ID | 19823814 |
| P5875 | ResearchGate publication ID | 26889450 |
| P2093 | author name string | Tone Westergren | |
| Betty Kalikstad | |||
| P2860 | cites work | Vitamin E supplementation for prevention of morbidity and mortality in preterm infants | Q24247665 |
| A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. | Q31121891 | ||
| Lessons from the E-Ferol tragedy | Q33456135 | ||
| Vitamin E treatment of focal segmental glomerulosclerosis: results of an open-label study. | Q33875413 | ||
| Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy | Q34300619 | ||
| The European perspective on vitamin E: current knowledge and future research | Q34905197 | ||
| Extemporaneous (magistral) preparation of oral medicines for children in European hospitals | Q35151846 | ||
| Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children | Q37300756 | ||
| 25 Hydroxyvitamin D and vitamin E absorption in healthy children and children with chronic intrahepatic cholestasis | Q38658703 | ||
| The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption | Q39849093 | ||
| The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. | Q40471017 | ||
| Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study | Q41739541 | ||
| Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity | Q41886821 | ||
| Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron | Q42237431 | ||
| Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: clinical and muscle biopsy findings and treatment with alpha-tocopherol | Q42261573 | ||
| Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids | Q42550176 | ||
| Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients | Q43839600 | ||
| Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats | Q44247758 | ||
| Effect of oral vitamin E supplementation in children with cholestasis. | Q44292240 | ||
| Vitamin E treatment in pediatric obesity-related liver disease: a randomized study | Q44694111 | ||
| Iatrogenic alcohol in medication | Q44876654 | ||
| The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers | Q45043067 | ||
| Serum vitamin E levels in the very low birth weight infant during oral supplementation | Q47209512 | ||
| Intestinal absorption of vitamin E in low birth weight infants | Q47239564 | ||
| Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. | Q51481737 | ||
| Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. | Q52082695 | ||
| Inter- and intra-individual variation in plasma and red blood cell vitamin E after supplementation. | Q54166560 | ||
| Increased tendency towards gingival bleeding caused by joint effect of α-tocopherol supplementation and acetylsalicylic acid | Q58123682 | ||
| The vitamin E status among glucose-6 phosphate dehydrogenase deficient patients and effectiveness of oral vitamin E | Q58492748 | ||
| Serum zinc and vitamin E concentrations in handicapped children treated with anticonvulsants | Q64943154 | ||
| Plasma free amino acid concentrations of breast-fed infants | Q67016461 | ||
| Serum alpha-tocopherol concentrations in preterm infants receiving less than 25 mg/kg/day alpha-tocopherol acetate supplements | Q67969590 | ||
| Carboxyhemoglobin concentration as an index of bilirubin production in neonates with birth weights less than 1,500 grams: a randomized double-blind comparison of supplemental oral vitamin E and placebo | Q68213007 | ||
| Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E | Q68307018 | ||
| Cyclosporin and vitamin E | Q68314552 | ||
| Oral vitamin E supplementation for the prevention of anemia in premature infants: a controlled trial | Q68924970 | ||
| Use and safety of elevated dosages of vitamin E in infants and children | Q69237291 | ||
| Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-alpha-tocopheryl polyethylene glycol-1000 succinate | Q69398061 | ||
| Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats | Q69680803 | ||
| Erythrocyte membrane lipid peroxidation before and after vitamin E supplementation in children with cholestasis | Q69702749 | ||
| Bilirubin production after supplemental oral vitamin E therapy in preterm infants | Q70075320 | ||
| Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants | Q70191592 | ||
| Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol | Q70274631 | ||
| Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis | Q70734270 | ||
| Familial hypobetalipoproteinaemia | Q70803905 | ||
| Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations | Q71043715 | ||
| Familial intrahepatic cholestasis associated with progressive neuromuscular disease and vitamin E deficiency | Q71397241 | ||
| Plasma alpha-tocopherol concentrations after supplementation with water- and fat-soluble vitamin E | Q71465571 | ||
| Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening | Q72360454 | ||
| High-dose tocopherol acetate therapy in epidermolysis bullosa siblings of the Cockayne-Touraine type | Q72756150 | ||
| Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen | Q73146514 | ||
| Extemporaneous (magistral) preparation of oral medicines for children in European hospitals | Q73512839 | ||
| Tocopherol in inborn errors of intermediary metabolism | Q73563221 | ||
| [Vitamin E mixture for children--treatment with a blindfold?] | Q82918526 | ||
| Vitamin E sufficiency in children with cholestasis: a comparison between erythrocyte peroxide hemolysis and serum alpha-tocopherol | Q93645696 | ||
| Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis | Q93650954 | ||
| P433 | issue | 2 | |
| P921 | main subject | heterocyclic compound | Q193430 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 109-118 | |
| P577 | publication date | 2009-10-13 | |
| 2010-02-01 | |||
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Dosage and formulation issues: oral vitamin E therapy in children | |
| P478 | volume | 66 |
| Q53766118 | Anti-oxidant profiles and markers of oxidative stress in preterm neonates. |
| Q48094959 | Effect of RRR-α-tocopherol supplementation on serum of breastfeeding women up to 60 days after delivery: a randomised controlled trial. |
| Q40567625 | Effect of Vitamin E With Therapeutic Iron Supplementation on Iron Repletion and Gut Microbiome in US Iron Deficient Infants and Toddlers |
| Q58611705 | The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis |
| Q61810343 | Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins |
| Q95557443 | α-Tocopherol in breast milk of women with preterm delivery after a single postpartum oral dose of vitamin E |
Search more.